Nephrotic syndrome caused by the angiogenesis inhibitor sorafenib

Ann Oncol. 2010 Jan;21(1):184-5. doi: 10.1093/annonc/mdp472. Epub 2009 Nov 4.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Angiogenesis Inhibitors / adverse effects*
  • Benzenesulfonates / adverse effects*
  • Carcinoma, Renal Cell / drug therapy
  • Humans
  • Indoles / therapeutic use
  • Kidney Neoplasms / drug therapy
  • Male
  • Middle Aged
  • Nephrotic Syndrome / chemically induced*
  • Nephrotic Syndrome / pathology
  • Nephrotic Syndrome / physiopathology
  • Niacinamide / analogs & derivatives
  • Phenylurea Compounds
  • Pyridines / adverse effects*
  • Pyrroles / therapeutic use
  • Sorafenib
  • Sunitinib

Substances

  • Angiogenesis Inhibitors
  • Benzenesulfonates
  • Indoles
  • Phenylurea Compounds
  • Pyridines
  • Pyrroles
  • Niacinamide
  • Sorafenib
  • Sunitinib